Methods of increasing muscle mass or muscle strength using...

Details Methods of increasing muscle mass or muscle strength using... Methods of increasing muscle mass or muscle strength using...

2007-04-19

2010-06-08

Landsman, Robert (Department: 1646)

Drug, bio-affecting and body treating compositions

Immunoglobulin, antiserum, antibody, or antibody fragment,...

C530S387100, C530S300000, C435S325000

Reexamination Certificate

active

07731961

ABSTRACT:
The disclosure provides novel antibodies against growth and differentiation factor-8 (GDF-8), including antibody fragments, which inhibit GDF-8 activity in vitro and in vivo. The disclosure also provides methods for diagnosing, preventing, or treating degenerative disorders of muscle, bone, or insulin metabolism.

REFERENCES:
patent: 4950221 (1990-08-01), Gordon
patent: 5308752 (1994-05-01), Campbell et al.
patent: 5639638 (1997-06-01), Wozney et al.
patent: 5700911 (1997-12-01), Wozney et al.
patent: 5723125 (1998-03-01), Chang et al.
patent: 5756457 (1998-05-01), Wang et al.
patent: 5827733 (1998-10-01), Lee et al.
patent: 5914234 (1999-06-01), Lee et al.
patent: 5928893 (1999-07-01), Kang et al.
patent: 5994618 (1999-11-01), Lee et al.
patent: 6004937 (1999-12-01), Wood et al.
patent: 6096506 (2000-08-01), Lee et al.
patent: 6340668 (2002-01-01), Celeste et al.
patent: 6368597 (2002-04-01), Strassmann et al.
patent: 6369201 (2002-04-01), Barker et al.
patent: 6407213 (2002-06-01), Carter et al.
patent: 6437111 (2002-08-01), Wozney et al.
patent: 6465239 (2002-10-01), Lee et al.
patent: 6607884 (2003-08-01), Lee et al.
patent: 6656475 (2003-12-01), Lee et al.
patent: 6673534 (2004-01-01), Lee et al.
patent: 6696260 (2004-02-01), Lee et al.
patent: 6835544 (2004-12-01), Mathews et al.
patent: 6891082 (2005-05-01), Lee et al.
patent: 7192717 (2007-03-01), Hill et al.
patent: 7202210 (2007-04-01), Wolfman et al.
patent: 7261893 (2007-08-01), Veldman et al.
patent: 7320789 (2008-01-01), Aghajanian et al.
patent: 7381528 (2008-06-01), Lee et al.
patent: 7393682 (2008-07-01), Lee et al.
patent: 2002/0150577 (2002-10-01), Lee et al.
patent: 2002/0157125 (2002-10-01), Lee et al.
patent: 2003/0074680 (2003-04-01), Lee et al.
patent: 2003/0104406 (2003-06-01), Wolfman et al.
patent: 2003/0162714 (2003-08-01), Hill et al.
patent: 2003/0180306 (2003-09-01), Hill et al.
patent: 2004/0055027 (2004-03-01), Lee et al.
patent: 2004/0077053 (2004-04-01), Lee et al.
patent: 2004/0138118 (2004-07-01), Wolfman et al.
patent: 2004/0142382 (2004-07-01), Veldman et al.
patent: 2004/0181033 (2004-09-01), Han et al.
patent: 2004/0223966 (2004-11-01), Wolfman et al.
patent: 2005/0043232 (2005-02-01), Lee et al.
patent: 2005/0257278 (2005-11-01), Lee et al.
patent: 2006/0240487 (2006-10-01), Nowak et al.
patent: 2006/0240488 (2006-10-01), Nowak et al.
patent: 2008/0178310 (2008-07-01), Lee et al.
patent: 2008/0213426 (2008-09-01), Lee et al.
patent: 1 061 940 (2003-12-01), None
patent: 1 444 985 (2004-08-01), None
patent: WO 94-21681 (1994-09-01), None
patent: WO 94-26892 (1994-11-01), None
patent: WO 96-01845 (1996-01-01), None
patent: WO 98/33887 (1998-08-01), None
patent: WO 98-33887 (1998-08-01), None
patent: WO98/35019 (1998-08-01), None
patent: WO 99/02667 (1999-01-01), None
patent: WO 99/06559 (1999-02-01), None
patent: WO 99-24058 (1999-05-01), None
patent: WO 99/24618 (1999-05-01), None
patent: WO 99/40181 (1999-08-01), None
patent: WO 99-45949 (1999-09-01), None
patent: WO 99-56768 (1999-11-01), None
patent: WO 00-11163 (2000-03-01), None
patent: WO 00-43781 (2000-07-01), None
patent: WO 01/05820 (2001-01-01), None
patent: WO 01-64888 (2001-09-01), None
patent: WO 02-09641 (2002-02-01), None
patent: WO 02-068650 (2002-09-01), None
patent: WO 03/072714 (2003-09-01), None
patent: WO 03/072715 (2003-09-01), None
patent: WO 2004/039948 (2004-05-01), None
patent: WO 2004-058988 (2004-07-01), None
patent: WO 2004/108157 (2004-12-01), None
patent: WO 2006/102574 (2006-09-01), None
patent: WO 2006/107611 (2006-10-01), None
Bays, Obesity Res. 12: 1197-1210, 2004.
Ridderstrale et al, Mol. Cell. Endocr. 209: 10-17, 2009.
Cefalu, W. Exp. Biol. and Med. 226: 13-26, 2001.
Florez, J. Clin. End. Metab. 93: 4633-4642, 2008.
Sanford et al, Thorax 57: 736-741, 2002.
Bellinge et al. (2005) “Myostatinand Its Implications on animal breeding: a review”Animal Genetics36: 1-6.
Casas et al. (1998) “Association of the Muscle Hypertrophy Locus with Carcass Traits in Beef Cattle,”J. Anim. Sci.76:468-473.
Dickman, Steven (1997) “Gene Mutation Provides More Meat on the Hoof,”Science277:1922-1923.
Grobet et al. (1997) “A Deletion in the Bovine Myostatin Gene Causes the Double-Muscled Phenotype in Cattle,”Nature Genetics17:71-74.
McKnight, Steven L. (1997) “Gatekeepers of Organ Growth,”Proc. Natl. Acad. Sci. USA94:12249-12250.
Mennissier, F. (1982) “Present State of Knowledge About the Genetic Determination of Muscular Hypertrophy or the Double Muscled Trait in Cattle,”Muscle Hypertrophy of Genetic Origin and Its Uses to Improve Beef Production: A Seminar in CEC Programme of Coordinated Research on Beef Production:387-428.
Vukicevic et al. (1996) “Induction of nephrogenic mesenchyme by osteogenic protein 1 (bone morphogenetic protein 7),”Proc Natl Acad Sci U S A. 93:9021-9026.
Supplemental European Search Report in EP 02 78 3984 dated Oct. 5, 2005.
International Search Report, mailed Feb. 4, 2003, based on PCT/US02/30452.
International Search Report, mailed Feb. 25, 2003, based on PCT/US02/03467.
Alexander et al., “Human Parathyroid Hormone 1-34 Reverses Bone Loss in Ovariectomized Mice,”J. Bone Miner. Res.16:1665-1673 (2001).
Alliel et al., “Testican, a Multidomain Testicular Proteoglycan Resembling Modulators of Cell Social Behaviour,”Eur. J. Biochem.214:347-350 (1993).
Amthor et al., “The Expression and Regulation of Follistatin and a Follistatin-like Gene During Avian Somite Compartmentalization and Myogenesis,”Dev. Biol.178:343-362 (1996).
Andersson et al., “Repeated in Vivo Determinations of Bone Mineral Density During Parathyroid Hormone Treatment in Ovariectomized Mice,”J. Endocrinol.170:529-537 (2001).
Ashmore et al., “Comparative Aspects of Muscle Fiber Types in Fetuses of the Normal and “Double-Muscled” Cattle,”Growth38:501-506 (1974) .
Attisano et al., “Activation of Signalling by the Activin Receptor Complex,”Mol. Cell. Biol.16:1066-1073 (1996).
Bakker et al., Duchenne and Becker Muscular Dystrophies. InDiagnostic Criteria for Neuromuscular Disorders, 2nd ed., Emery, ed., Royal Society of Medicine Press, 1998; pp. 1-4.
Bartholin et al., “FLRG, an Activin-Binding Protein, is a New Target of TGFβ Transcription Activation Through Smad Proteins,”Oncogene20:5409-5419 (2001).
Bogdanovich et al., “Functional Improvement of Dystrophic Muscle by Myostatin Blockade,”Nature 420:418-421(2002).
Brown et al., “Physicochemical Activation of Recombinant Latent Transforming Growth Factor-beta's 1, 2, and 3,”Growth Factors3:35-43 (1990).
Bulfield et al., “X Chromosome-Linked Muscular Dystrophy (mdx) in the Mouse,”Proc. Natl. Acad. Sci. U.S.A.81:1189-1192 (1984).
Chamov and Ashkanazi,TIBTECH14:52-60 (1996).
D'Angelo et al., “Authentic Matrix Vesicles Contain Active Metalloproteases (MMP),”J. Biol. Chem.276:11347-11353 (2001).
Derynck et al., “Human Transforming Growth Factor-β Complementary DNA Sequence and Expression in Normal and Transformed Cells,”Nature316:701-705 (1985).
Donoghue et al., “Rostrocaudal Gradient of Transgene Expression in Adult Skeletal Muscle,”Proc. Natl. Acad. Sci. U.S.A.88:5847-5851 (1991).
Emery, “The Muscular Dystrophies,”Lancet359:687-695 (2002).
Escolar et al., “Pharmacologic and Genetic Therapy for Childhood Muscular Dystrophies,”Current Neurology and Neuroscience Reports1:168-174 (2001).
Gamer et al., “A Novel BMP Expressed in Developing Mouse Limb, Spinal Cord, and Tail Bud Is a Potent Mesoderm Inducer inXenopusEmbryos,”Dev. Biol.208:222-232 (1999).
Gamer et al., “Gdf11 is a Negative Regulator of Chondrogenesis and Myogenesis in the Developing Chick Limb,”Dev. Biol.229:407-420 (2001).
Gentry et al., “The Pro Domain of Pre-Pro-Transforming Growth Factor β1 When Independently Expressed Is a Functional Binding Protein for the Mature Gro

Affiliated with

Also associated with

Rating

Methods of increasing muscle mass or muscle strength using... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods of increasing muscle mass or muscle strength using..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of increasing muscle mass or muscle strength using... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4209850